COVID-19 Vaccine Development

A SARS-CoV-2 vaccine would be a very powerful tool to slow down the COVID-19 pandemic. Well over a hundred vaccine candidates are in development, with some already being tested for safety and efficacy, or in phase I clinical trials. This feed follows the latest studies on vaccine design and development.

May 20, 2020
Open Access

An overview of COVID-19

Journal of Zhejiang University. Science. B
Yu ShiZhi Chen
May 19, 2020
Open Access

Design of multi-epitope vaccine candidate against SARS-CoV-2: a In-Silico study

Journal of Biomolecular Structure & Dynamics
Abraham Peele KVenkateswarulu Tc
May 11, 2020

Emergence of genomic diversity and recurrent mutations in SARS-CoV-2

Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases
Lucy van DorpFrançois Balloux
May 10, 2020
Open Access

Rapid COVID-19 vaccine development

Barney S Graham
May 25, 2020

Ongoing Challenges Faced in the Global Control of COVID-19 Pandemic

Archives of Medical Research
Guillermo I Perez Perez, Amin Talebi Bezmin Abadi
May 24, 2020
ReviewOpen Access

A Guide to COVID-19: a global pandemic caused by the novel coronavirus SARS-CoV-2

The FEBS Journal
Cassandra L AtzrodtThomas P Clements
May 14, 2020
ReviewOpen Access

Influenza Virus Like Particles (VLPs): Opportunities for H7N9 Vaccine Development

Peter Pushko, Irina Tretyakova
June 1, 2020

The starting line for COVID-19 vaccine development

Nelson Lee, Allison McGeer
May 21, 2020

SARS-CoV-2: The Path of Prevention and Control

Infectious Disorders Drug Targets
Amal A MohamedSherief Abd-Elsalam
May 15, 2020
Open Access

Rational Vaccine Design in the Time of COVID-19

Cell Host & Microbe
Dennis Burton, Laura M Walker
May 9, 2020
Open Access

Lack of cross-neutralization by SARS patient sera towards SARS-CoV-2

Emerging Microbes & Infections
Danielle E AndersonLin-Fa Wang
May 28, 2020
ReviewOpen Access

The early landscape of COVID-19 vaccine development in the UK and rest of the world

Hannah R SharpeTeresa Lambe

Sign up to follow this feed and discover related papers.

Related Feeds

AI-driven COVID-19 Management

Artificial intelligence (AI) offers a powerful new tool that could potentially be instrumental in controling and managing the SARS-CoV-2 virus. The papers in this feed report on the applications of AI to the current pandemic, which may be able to predict the location of the next outbreak, or facilitate new drug design.


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

COVID-19 Clinical Diagnosis

COVID-19 patients typically present with high fever and a persistent cough. This feed focuses on clinical diagnosis, including RT-PCR testing for the presence of SARS-CoV-2 and radiographic assessment of lungs.

COVID-19 Clinical Management

While most COVID-19 infections cause only mild to moderate symptoms, severely affected patients, such as those presenting with pneumonia, ARDS or septic shock, require hospitalization. This feed focuses on clinical management of patients using oxygen therapy, ventilation, and other treatment strategies, and covers some medical case reports.

COVID-19 Comorbidities

COVID-19 represents a particular challenge to people with serious chronic medical conditions such as diabetes, hypertension, cardiovascular disease, and chronic lung disease. Research into the intersection between comorbidities and COVID-19 is focusing on risks and treatment outcomes for these patients.

COVID-19 Complications

A growing number of complications associated with COVID-19 has been identified. This feed focuses primarily on cardiovascular and respiratory manifestations in severely ill patients.

COVID-19 Covalescent Plasma Therapy

Convalescent plasma therapy, where passive polyclonal antibody obtained from recovered patients are used to provide immediate immunity, has been tested in respiratory infections such as the 2009-2010 H1N1 influenza virus pandemic and the 2003 SARS-CoV-1 epidemic. This feed follows ongoing research efforts and clinical trials exploring covalescent plasma therapy as a potential treatment strategy for COVID-19.

COVID-19 Epidemiology and Demography

Epidemiological studies play a crucial role in understanding and managing the progression of COVID-19. Research followed in this feed includes studies of transmission dynamics and the change of the basic reproductive number (R) as new pubic health measures take effect.

COVID-19 Immune Response

Understanding the innate and acquired immune response to SARS-CoV-2 is essential for development of COVID-19 therapeutic treatment and design of prophylactic vaccines. This feed surfaces immunological studies, including studies into the cytokine storm that has been observed in severely ill patients.

COVID-19 Immunopathology

The research highlighted in this feed investigates the immunopathology seen in severely ill COVID-19 patients, which often resembles the cytokine storm syndrome: uncontrolled immune activation generates excessive release of cytokines, resulting in hyperinflammation and multi-organ disease.

© 2020 Meta ULC. All rights reserved